Chatbots and Pharma Research — The Path to Real-World Evidence and Patient Adherence


Manage episode 226732791 series 2408553
By Greg Kefer, CMO, LifeLink. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

In 2018, the average cost of developing a new drug and bringing it to market topped $2.1 billion—up $362 million from 2017 according to a Deloitte survey. One of the challenges pharmaceutical companies face is attrition and non-adherence during patient trials. Traditional methods, focused on call centers, complex documentation and feedback limitations, lack the ability to collect enough real-world evidence to get the full patient experience picture.

In this episode, Justin Mardjuki and Greg Kefer talk about the challenges the industry faces and how chatbots can be a viable option to improve the research process, during both trial and in-market phases across large patient populations.

22 episodes